(Q34267831)
Statements
Zoledronic acid reduces bone loss and tumor growth in an orthotopic xenograft model of osteolytic oral squamous cell carcinoma (English)
Chelsea K Martin
Jillian L Werbeck
Nanda K Thudi
Lisa G Lanigan
Tobie D Wolfe
Ramiro E Toribio
19 October 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference